<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03027713</url>
  </required_header>
  <id_info>
    <org_study_id>dawNAVA</org_study_id>
    <nct_id>NCT03027713</nct_id>
  </id_info>
  <brief_title>Diaphragmatic Activity During Weaning With NAVA, a Pilot Study (NAVA: Neurally Adjusted Ventilatory Assist)</brief_title>
  <acronym>NAVA</acronym>
  <official_title>Diaphragmatic Activity During a Postoperative Rapid Weaning Protocol With Neurally Adjusted Ventilatory Assist in Healthy Lung Patients, a Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para la Investigación del Hospital Clínico de Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para la Investigación del Hospital Clínico de Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe the diaphragm electromyographic activity (Edi) in
      healthy lung patients due to obtain a reference to guide the weaning in those patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We obtained the Edi recording data at each NAVA level during the weaning in NAVA group, and
      we compared the respiratory parameters between the PSV and NAVA groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic electromyographic activity description</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Postoperative Patients</condition>
  <arm_group>
    <arm_group_label>NAVA group with a specific catheter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients were allocated in the NAVA weaning protocol group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV group without a specific catheter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients were allocated in the PSV (pressure-support ventilation) weaning protocol group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>weaning protocol</intervention_name>
    <description>The patients were allocated in the NAVA weaning protocol group o in the PSV weaning protocol group</description>
    <arm_group_label>NAVA group with a specific catheter</arm_group_label>
    <arm_group_label>PSV group without a specific catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were scheduled for elective major surgery in which admission to the CCU
             (critical care unit) for postoperative care and short-term mechanical ventilation with
             rapid weaning were anticipated.

        Exclusion Criteria:

          -  Preoperative altered central nervous system, neuromuscular or lung disease and ASA
             (american society of anesthesiologists) classification group IV or NYHA (New York
             heart association) class IV in the case of cardiac patients. At the CCU, before
             randomisation, we also excluded patients requiring reoperation, and those who
             exhibited significant postsurgical bleeding, the development of myocardial infarction,
             and hemodynamic instability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mar Garzando Civera, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación para la investigación del Hospital Clínico Universitario de Valencia</affiliation>
  </overall_official>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2016</study_first_submitted>
  <study_first_submitted_qc>January 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2017</study_first_posted>
  <last_update_submitted>January 19, 2017</last_update_submitted>
  <last_update_submitted_qc>January 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación para la Investigación del Hospital Clínico de Valencia</investigator_affiliation>
    <investigator_full_name>F Javier Belda</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>NAVA: neurally adjusted ventilatory assist</keyword>
  <keyword>Diaphragm electromyographic activity</keyword>
  <keyword>Weaning</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Shared data will be anonymous</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

